CAS: 694-52-0; 4-Fluoropyridine

该化合物是一种环环环的杂交芳香化合物,其特点是在4级中以氟替代氟化物的环状,其分子式为C5H4FNF,分子重量约为99.09克/摩尔,这种淡黄色液体无色以其独特的气味闻名,在水和有机溶剂中可溶解. 4-氟丙烯丙烯基因环中的氮原子而具有基本特性,使它成为一个薄弱的基质.它被用作各种药物,农业化学品和其他有机化合物合成的中间体.氟基原子的存在可增强化合物的回动性并影响其生物活动.安全考虑包括谨慎地处理它,因为它可能对皮肤和眼睛产生刺激,并建议由于它的挥发性而进行适当的通风.总体而言,4氟丙基丁是有机合成和研究应用中的一种有价值的化合物.

结构式图片

上下游产品

4-aminopyridine hydrogen fluoride water pyridine 1-(4'-pyridyl)-4-pyridone 5,8-endoxo-5,8-dihydroisoquinoline 3-methyl-N-(4-pyridyl)indole 4-fluoro-3-methylsilylpyridine

合成工艺路线路线简述

    Potassium Pyridine-4-Trifluoroborate置于potassium Fluoride,Copper(II) Bis(Trifluoromethanesulfonate)体系中,用 乙腈 作为反应溶剂,化学反应 20.0H,反应生成 4-氟吡啶
    参考文献:Cu(Otf)2-介导的芳基三氟硼酸盐与氟化钾的氟化
    标题:Cu(Otf)2-介导的芳基三氟硼酸盐与氟化钾的氟化
    摘要:本通讯描述了 Cu(Otf)2 介导的芳基三氟硼酸盐与 Kf 的氟化.该反应在温和条件下进行(60°C,20 小时),显示出广泛的底物范围和官能团耐受性.cu 被提议在这种转化中扮演两个独立的角色:(1)作为芳基-F 偶联的介体和(2)作为氧化剂用于获得提议的 Cu(iii)(芳基)(f)中间体.
    DOI:10.1021/ja408607R

    海关参考信息

    专利信息


    专利号:US-10011567-B1
    优先权日:2017-03-09
    标题 :Method for the synthesis of acrylate derivatives
    发明人:WANG MINGWEN; ZHANG YUE
    权利人:INNOSCI LLC
    摘要:The present invention provides an improved synthesis of a salt of acrylate derivatives. The synthesis generally includes the preparation of an ester or an amide containing a leaving group followed by the formation of a salt.

    专利号:WO-2025122636-A1
    优先权日:2023-12-04
    标题:Method for the synthesis of acrylate derivatives
    发明人:CAICEDO-CARVAJAL CARLOS; KATZ JORDAN; CHOI SEAN
    权利人:ORTHOBOND CORP
    摘要:The disclosure relates to the synthesis of quaternary salts of various acrylates in high yield and high purity.

    专利号:WO-2023213264-A1
    优先权日:2022-05-05
    标 题 :Synthesis of amide compound and use thereof
    发明人:WANG ZHAOYIN; ZHANG JIAN; CAO JINRUI
    权利人:SHANGHAI INST ORGANIC CHEMISTRY CAS
    摘要:The present invention relates to a novel oleanamide derivative for activating a KEAP/NRF2/ARE signaling pathway. The compound of the present invention is represented by general formula (I), wherein L, R 3 , R 4 , Z, and n are set forth in the description specification and the claims. Also disclosed are a method for preparing the compound represented by general formula I and an activity test result thereof for activating the KEAP/NRF2/ARE signaling pathway. The compound represented by general formula (I) of the present invention can be used for treating and preventing multiple sclerosis (MS), Alzheimer's disease (AD), Parkinson's disease (PD), Huntington's disease (HD), amyotrophic lateral sclerosis (ALS), Friedreich's ataxia (FRDA), spinal muscular atrophy (SMA), neuromyelitis optica (NMO), spinocerebellar ataxia (SCA), and other neurodegenerative diseases, and can also be used for treating cerebral apoplexy, autoimmune diseases, diabetes, kidney diseases, and other chronic diseases.

    专利号:US-2017355648-A1
    优先权日:2016-04-26
    标题 :Synthesis of meta-substituted [18f]-3-fluoro-4-aminopyridines by direct radiofluorination of pyridine n-oxides

    专利号:US-8697888-B2
    优先权日:2012-01-06
    标题 :Substituted (1-(methylsulfonyl)azetidin-3-yl)(heterocycloalkyl)methanone analogs as antagonists of muscarinic acetylcholine M1 receptors
    发明人:LINDSLEY CRAIG W; CONN P JEFFREY; WOOD MICHAEL R; MELANCON BRUCE J; CHEUNG YIU-YIN
    权利人:UNIV VANDERBILT
    摘要:In one aspect, the invention relates to substituted (1-(methylsulfonyl)azetidin-3-yl)(heterocycloalkyl)methanone analogs, derivatives thereof, and related compounds, which are useful as antagonists of the muscarinic acetylcholine receptor M 1 (mAChR M 1 ); synthesis methods for making the compounds; pharmaceutical compositions comprising the compounds; and methods of treating neurological and psychiatric disorders associated with muscarinic acetylcholine receptor dysfunction using the compounds and compositions. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.

    专利号:US-10995078-B2
    优先权日:2013-03-13
    标 题:Compounds and compositions for inhibition of FASN
    发明人:BAIR KENNETH W; LANCIA JR DAVID R; LI HONGBIN; LOCH JAMES; LU WEI; MARTIN MATTHEW W; MILLAN DAVID S; SCHILLER SHAWN E R; TEBBE MARK J
    权利人:FORMA THERAPEUTICS INC
    摘要:The present invention relates to compounds and composition for inhibition of FASN, their synthesis, applications, and antidotes. An illustrative compound of the invention is shown below:
    阜新金特莱氟化学有限责任公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.jtlchem.com
    企业联系电话:0418-8229899👤
    📞阜新金特莱氟化学有限责任公司 ⚠️参考联系方式
    联系人:那经理
    电话:0418-8229899

    传真:0418-8229699
    邮箱:natj@jtlchem.com
    通信地址: 辽宁省阜新氟产业开发区化工七路5号(阜蒙县伊吗图镇)
    邮编: 123129
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:辽宁省阜新氟产业开发区化工七路5号(阜蒙县伊吗图镇)
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    南京华安药业有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.nanjingpharma.com
    电话: 025-58394007👤
    📞南京华安药业有限公司 ⚠️参考联系方式

    销售电话:025-58394007
    邮箱:sales@nanjingpharma.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    摘要:Wang, X.; Hu, J., Science of Synthesis: Modern Strategies in Organofluorine Chemistry, (2025) 2.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知